Testing effectiveness (Phase 2)Study completedNCT04347239
What this trial is testing
Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19
Who this might be right for
Coronavirus Disease 2019
CytoDyn, Inc. 484
Showing 20 of 0 results